Cytokinetics (CYTK) Change in Cash (2016 - 2025)
Historic Change in Cash for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $48.0 million.
- Cytokinetics' Change in Cash rose 25980.35% to $48.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$18.2 million, marking a year-over-year decrease of 13930.8%. This contributed to the annual value of -$18.2 million for FY2024, which is 13930.8% down from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Change in Cash is $48.0 million, which was up 25980.35% from -$143.3 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Change in Cash registered a high of $139.7 million during Q3 2020, and its lowest value of -$143.3 million during Q3 2024.
- In the last 5 years, Cytokinetics' Change in Cash had a median value of $12.0 million in 2020 and averaged $2.9 million.
- Over the last 5 years, Cytokinetics' Change in Cash had its largest YoY gain of 254892.85% in 2020, and its largest YoY loss of 358094.35% in 2020.
- Over the past 5 years, Cytokinetics' Change in Cash (Quarter) stood at -$117.8 million in 2020, then surged by 118.76% to $22.1 million in 2021, then tumbled by 276.69% to -$39.1 million in 2022, then surged by 134.14% to $13.3 million in 2023, then soared by 259.8% to $48.0 million in 2024.
- Its Change in Cash stands at $48.0 million for Q4 2024, versus -$143.3 million for Q3 2024 and $70.2 million for Q2 2024.